Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arachidonic acid pathway enzymes are a group of enzymes responsible for the metabolism of arachidonic acid (AA), a polyunsaturated fatty acid released from membrane phospholipids. These enzymes catalyze the conversion of AA into various bioactive lipid mediators, collectively known as eicosanoids, which play crucial roles in inflammation, immunity, cardiovascular function, and other physiological and pathological processes. Key enzymes include phospholipase A2 (PLA2), cyclooxygenases (COX-1 and COX-2), lipoxygenases (ALOX5, ALOX12, ALOX15), and cytochrome P450 monooxygenases. Products of these pathways regulate cell proliferation, differentiation, apoptosis, and fibrosis, and are implicated in various diseases. These enzymes are major drug targets for treating inflammatory disorders.
Enzyme inhibition, receptor antagonism, modulation of enzymatic activity
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arachidonic Acid Pathway Enzymes (AA Pathway Enzymes).